Syringe, सुई पर 1200% तक मुनाफा | Consumer Adda | CNBC Awaaz

In a report released by National Pharmaceutical Pricing Authority (NPPA), maximum retail prices of syringes are marked up to 1200% higher and this phenomenon is becoming a profit making mechanism. When will this practice end?
CNBC Awaaz is India’s number one business channel and an undisputed leader in business news and information for the last ten years. Our channel aims to educate, inform and inspire consumers to go beyond limitations, with practical tips on personal finance, investing, technology, consumer goods and capital markets. Policymakers and business owners alike have grown to trust CNBC Awaaz as the most reliable source with its eye on India’s business climate. Our programming gives consumers a platform to make decisions with confidence.
Subscribe to the CNBC Awaaz RUclips channel here: goo.gl/g3rzrW
Follow CNBC Awaaz on Twitter: / cnbc_awaaz
Like us on our CNBC Awaaz Facebook page: / cnbcawaazindia

[@ampmskm]

1200% is 12 times not 1200 times.

[@ShahidAnsari_4300]

कभी जेनरिक दवाओ की MRP पर भी ध्यान दीजिए लोगों की जेब पर खुला डाका डाला जा रहा है?

[@drbhagat971]

No point in criticising a system when you don’t know ABCD of that and that too such important system.

[@apoorvshukla3687]

Sir I want to invest in syring manufacturing so how can I start it and how much capital se required